Overview

Pharmacokinetics of FDL169 in Healthy Female Subjects

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
To determine the pharmacokinetics of single and multiple doses of FDL169 in healthy female subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Flatley Discovery Lab LLC